NeoImmuneTech네오이뮨텍
950220 · KOSDAQ · ₩950220 · 네오이뮨텍
₩1,632▼ ₩45 (2.68%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Investor relations (IR) event기업설명회(IR)개최Oct 30, 2026Open on DART
Predicted impact: Low
- Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Oct 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Sep 4, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Aug 19, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (NTI7 흉선 기능 관련 적응증에 대한 독점적 기술이전 계약 체결)Aug 19, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (NIT110(재발성·불응성 진행성 고형암, NTI7 및 키트루다 병용요법) 임상 1b/2a상 임상시험결과보고서(CSR) 수령)Aug 18, 2026Open on DART
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 12, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 13, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
- Adjustment of Conversion Price (1st Series CB)전환가액의조정 (제1회차 CB)Jun 30, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Third-Party Allotment Rights Offering)증권발행결과(자율공시) (제3자배정 유상증자)Jun 18, 2026Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Jun 10, 2026Open on DART
- Trading halt주권매매거래정지해제 (액면병합 주권 변경상장)Jun 9, 2026Open on DART
- [Corrected Filing] KOSDAQ-listed Foreign Company External Auditor Appointment/Dismissal Report[기재정정]코스닥시장상장외국법인외부감사인선임ㆍ해임신고서Jun 5, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 5, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 14, 2026Open on DART
- Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)May 12, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획자진취하등) (NTI7(NIT119, 비소세포폐암) 임상 2상 시험 자진취하)Apr 24, 2026Open on DART
- [Amended] Decision on Consolidation of Depositary Receipts (DR)[기재정정]증권예탁증권(DR)병합결정Apr 23, 2026Open on DART
- [Amended] Decision on Share Consolidation[기재정정]주식병합결정Apr 23, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Change of CEO대표이사변경Mar 27, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 24, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 13, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Mar 13, 2026Open on DART
- Consolidation of Depositary Receipts (DR) Decision증권예탁증권(DR)병합결정Mar 10, 2026Open on DART
- Share Consolidation Decision주식병합결정Mar 10, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 10, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 10, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 10, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 10, 2026Open on DART
- KOSDAQ Market Notice of Appointment/Dismissal of External Auditor for Foreign Corporation Listed on KOSDAQ코스닥시장상장외국법인외부감사인선임ㆍ해임신고서Feb 25, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 11, 2026Open on DART
- [Amended] Exercise of Conversion Rights (1st Series)[기재정정]전환청구권행사 (제1회차)Jan 9, 2026Open on DART
- Exercise of Conversion Rights (1st Series)전환청구권행사 (제1회차)Dec 24, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (겸상적혈구질환 치료제 북미 지역 제반 권리(판매권, 유통권, 상표권 등)에 대한 라이선스 도입의 건)Dec 17, 2025Open on DART
- Other management matters기타경영사항(자율공시) (제12기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)Dec 16, 2025Open on DART
- Adjustment of Conversion Price (1st Series)전환가액의조정 (제1회차)Dec 1, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 7, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 16, 2025Open on DART
- Change of CEO대표이사변경Oct 10, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 18, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: NeoImmuneTech / 네오이뮨텍 / 950220 / KRX:950220
Source: KRX statistical information